By Dr. Apurba Kumar Sarma, MBBS, MS (General Surgery), MCh (CVTS) Founder, Chairman & Managing Director, Tulip Mediworld Superspeciality Hospital, Guwahati Cardiovascular & Thoracic Surgeon | 25+ years experience | 7,000+ heart surgeries
Quick Takeaways
- Not every heart blockage needs surgery – but certain patterns of blockage consistently do better with bypass than with any other treatment.
- The seven indications in this article are grounded in international surgical guidelines and landmark clinical trials.
- If you have been told you “might need bypass surgery,” understanding these criteria will help you have a more informed conversation with your surgical team.
- The decision to recommend bypass surgery is never taken lightly – it is recommended when the evidence clearly shows that surgery offers you a better long-term outcome than the alternatives.
- A second opinion is always your right – and a good cardiac surgeon will never discourage you from seeking one.
In 25 years as a cardiac surgeon in Guwahati, I have had hundreds of conversations with patients who came to me asking one question: “Do I really need surgery?”
Sometimes they had been told by multiple doctors that surgery was necessary, but they were hoping someone would offer a different answer. Sometimes they had been living with chest pain for years, managing with medications, and were only now facing the reality that the medications were no longer enough. Sometimes they had come from a smaller town in Assam or from Manipur or Nagaland, having been referred by a physician who said “go to the surgeon in Guwahati” – without fully explaining why.
Here is how I answer that question.
The decision to recommend bypass surgery – formally called Coronary Artery Bypass Grafting, or CABG – is never taken lightly. It is recommended when the evidence, the anatomy of a patient’s coronary arteries, and their overall clinical picture clearly show that the risk of not operating exceeds the risk of the surgery itself. For the conditions I describe below, that evidence is strong, consistent, and supported by decades of data from trials involving hundreds of thousands of patients worldwide.
When a cardiologist performs a coronary angiogram – an X-ray of the heart’s arteries using a contrast dye – the image shows exactly where blockages are, how severe they are, and how many arteries are affected. The pattern of those blockages is the primary basis for the surgical recommendation.
Symptoms matter, but they are not the whole picture. Some patients with severe multi-vessel coronary artery disease have surprisingly mild symptoms – their hearts have adapted, but the underlying danger is significant. Others have severe symptoms from relatively limited disease that can be managed with medication or a single stent. The anatomy is the guide.
Triple vessel disease means that all three of the major coronary arteries – the left anterior descending (LAD), the circumflex, and the right coronary artery – have significant blockages. Together, these arteries supply blood to virtually the entire heart muscle. When all three are compromised, the heart is living on borrowed time.
For triple vessel disease, bypass surgery consistently outperforms coronary stenting (PCI – Percutaneous Coronary Intervention) in long-term outcomes. The landmark SYNTAX trial, which followed over 1,800 patients with triple vessel disease and left main disease, found that surgical patients had significantly lower rates of major cardiac events at 5 years compared to patients treated with stents. This has been the foundation of international CABG guidelines for over a decade.
The left main coronary artery is sometimes called the “widow-maker” – and for good reason. It branches into the two arteries that supply the majority of the left ventricle, the heart’s main pumping chamber. A significant blockage in the left main artery means that a large portion of the heart is at immediate risk.
Left main disease is an almost universally surgical indication. Even in an era of advanced stenting technology, ACC/AHA guidelines consistently recommend surgical bypass as the preferred treatment for significant left main disease, except in specific anatomical situations where stenting is technically appropriate. The reason: bypass provides a more durable, complete revascularisation of these critical territories.
Diabetes changes the biology of coronary artery disease in important ways. Diabetic patients tend to develop more diffuse, widespread disease that affects smaller vessels. Stents in diabetic patients re-block at significantly higher rates than in non-diabetic patients – a phenomenon called in-stent restenosis.
For diabetic patients with multivessel coronary disease, bypass surgery offers substantially better long-term outcomes than stenting. The FREEDOM trial, published in the New England Journal of Medicine, demonstrated that CABG in diabetic patients with multivessel disease reduced death and heart attack at 5 years compared to PCI – a finding that directly shapes how we make decisions for this patient group.
If you are diabetic and have been told you have blockages in multiple arteries, a surgical opinion is not just reasonable – it is specifically recommended in international guidelines.
Coronary stenting (angioplasty with stent placement) is an excellent treatment for many patients with coronary artery disease – particularly single vessel disease or discrete blockages amenable to a stent. But stents can re-block, and anatomy that was once suitable for stenting can become technically unsuitable for another attempt.
When a patient has had one or more previous stent procedures and the artery has re-blocked, or when the anatomy has evolved in a way that makes further stenting either technically complex or unlikely to provide durable relief, bypass surgery becomes the appropriate solution. The bypass grafts route blood around the diseased segment entirely – they do not attempt to open a blocked artery but instead create a new pathway.
Angina – the chest pain or heaviness caused by insufficient blood supply to the heart – is the symptom most directly improved by bypass surgery. When angina significantly limits daily life despite optimal medical therapy (the best medications at appropriate doses), and when the coronary anatomy shows disease suitable for bypass, surgery is strongly indicated.
“Optimal medical therapy” is not the same as “taking some tablets.” It means maximum tolerated doses of beta-blockers, nitrates, and other antianginal medications, adjusted by a cardiologist. If angina persists despite this, the blockages are limiting blood flow in a way that medication cannot overcome – and bypass surgery addresses the underlying anatomical problem directly.
Ejection fraction is the percentage of blood the left ventricle pumps out with each beat. A normal ejection fraction is 55–70%. When it falls below 40%, the heart is significantly weakened.
Reduced ejection fraction combined with multivessel coronary artery disease is a situation where bypass surgery can do something truly powerful: restore blood flow to hibernating heart muscle – tissue that has been chronically deprived of adequate blood supply and is therefore not contracting normally, but is still alive and capable of recovering function once blood flow is restored. This phenomenon, called myocardial hibernation, means that bypass surgery in patients with a low ejection fraction can not only protect against future events but actually improve the heart’s pumping function over time.
This is one of the indications where delaying surgery carries serious consequences, and where the risk-benefit calculation most clearly favours operating.
Some patterns of coronary artery disease – very long blockages, extensively calcified arteries, very small vessel diameters, disease affecting branching points – are simply not suitable for safe or durable stenting. The technical demands of placing a stent in these vessels either make the procedure itself high-risk or make the long-term outcome of the stent poor.
In these situations, even if the disease pattern might otherwise have been considered for stenting, surgery is the appropriate treatment. This is not a failure of modern interventional cardiology – it is a recognition that bypass surgery and stenting are complementary tools, not competing ones, and that selecting the right tool for the right anatomy is what protects the patient.
| Indication | Why Surgery Is Preferred | Alternative Considered? |
|---|---|---|
| Triple vessel disease | SYNTAX trial: better 5-year outcomes with CABG | Stenting considered; surgery preferred by guidelines |
| Left main disease | Supplies majority of heart; durability of bypass superior | Stenting in specific low-complexity anatomy |
| Multivessel disease + diabetes | Higher stent re-blockage rates in diabetic vessels | FREEDOM trial: CABG superior at 5 years |
| Failed or repeat PCI | Re-blockage after stenting; anatomy no longer suitable for stent | Stenting re-attempted only if anatomy permits |
| Severe uncontrolled angina | Blockages beyond what medication can compensate | Maximum medical therapy first |
| Low ejection fraction + multivessel disease | CABG restores hibernating muscle, improves pumping function | Medical therapy insufficient for hibernating myocardium |
| Complex coronary anatomy | Stenting technically too high-risk or non-durable | Anatomy-specific decision |
This is a fair and completely reasonable question – and I encourage my patients to ask it.
For mild to moderate single-vessel disease without the features described above, a trial of lifestyle modification and optimal medical therapy is entirely appropriate. Many patients do very well on medications alone, and the goal is always to use the least invasive effective treatment.
But for the seven indications listed above, delay carries real risk. An unrevascularised left main lesion is an unpredictable emergency waiting to happen. Triple vessel disease in a diabetic patient on medications alone has a significantly worse long-term prognosis than the same patient who has had bypass surgery.
I never pressure a patient into surgery. My job is to give you the information to make the right decision for your life – not to make that decision for you. But I would not be serving you well if I presented delay as a neutral choice when the evidence says otherwise.
Lifestyle changes – weight loss, regular exercise, quitting smoking, managing blood pressure and diabetes – are among the most powerful things you can do for your heart. They reduce the progression of coronary artery disease and significantly reduce the risk of a heart attack.
However, they cannot physically remove or reverse established significant blockages. Once you have a 70–80% or greater blockage in a major coronary artery, no amount of exercise or dietary change will reopen that artery to adequate blood flow. Lifestyle changes protect what is working; they cannot undo what has already happened. The surgery addresses the anatomy; the lifestyle changes protect the surgery’s results.
It depends entirely on the specific indication. For some patients with borderline anatomy, close monitoring with optimal medical therapy is a reasonable option. For others – particularly those with left main disease, triple vessel disease with significantly reduced heart function, or severe uncontrolled angina – choosing not to operate carries a meaningfully elevated risk of heart attack, sudden cardiac death, or progressive heart failure.
I always have this conversation honestly with my patients, and I present the data rather than making the decision for them. But I also make sure they understand the consequences of each path clearly – without softening the parts that are uncomfortable to hear.
You should always get a second opinion before any major surgery. Any surgeon who discourages you from seeking one is not serving your interests. A genuine surgical recommendation should be strong enough to withstand independent scrutiny – and most of the time, it is.
If you have been referred from another part of Northeast India and want an assessment from a cardiac surgeon in Guwahati, you can contact Tulip Mediworld Superspeciality Hospital to arrange a consultation. Bring your angiogram report and images, your echocardiogram, and your cardiologist’s referral letter. I will give you my honest assessment – and if medications or stenting are a genuinely appropriate alternative for your anatomy, I will tell you that too.
When I recommend bypass surgery to a patient, it is because I genuinely believe it will give them the best chance at a long, quality life. I have that conversation honestly, in plain language, without hiding the risk of surgery or the risk of not operating. I encourage every question. I ask patients to bring their families. I make sure they understand not just what we are doing but why.
After 7,000+ heart surgeries, I have seen what bypass surgery gives back to people who truly needed it: a return to walking without chest pain, a return to sleeping without fear, a return to watching their grandchildren grow. The surgery is not the end of the story. It is the start of a better chapter.
If you or someone you love has been told they may need bypass surgery and you want a consultation in Guwahati, contact us at drapurbasarma.in or call Tulip Mediworld Superspeciality Hospital at +91 99540 15111 or 1800 890 4655. Patients travel to us from across Assam, Manipur, Nagaland, Meghalaya, Tripura, and Arunachal Pradesh – you do not need to travel further.
For a complete guide to what bypass surgery involves, recovery, and life after the procedure, read our comprehensive life after heart surgery recovery guide.
About the Author
Dr. Apurba Kumar Sarma, MBBS, MS (General Surgery), MCh (CVTS) is a cardiovascular and thoracic surgeon with over 25 years of experience and 7,000+ successful heart surgeries. He is the Founder, Chairman and Managing Director of Tulip Mediworld Superspeciality Hospital, GS Road, Rukmini Gaon, Guwahati, Assam – 781022. He is a Fellow of the Indian Association of Cardiovascular-Thoracic Surgeons and a Life Member of the Indian Medical Association.
This article is for informational purposes only and does not constitute medical advice. Please consult a qualified cardiac surgeon for evaluation and treatment specific to your condition.
